Description
KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
PRINCIPIO ACTIVO: MELISSA OFICINLIS PASIFLORA INCARNATA
La dosis se ajusta con base en parámetros hematológicos
OTICA CAJA C/ FCO
Requiere monitoreo neuromuscular continuo
FORTICE II SUP ALIM 30 CPR PIERRE FABRE FARMA DE MEXICO SA DE CV KADCYLA® 160 mg es un
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
